Company: XERI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001477932-25-003761
Chunk: 43

Company: XERIANT, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 43
---
327) $(1,302,552) $(1,909,600)                 Net loss per common share - basic and diluted $(0.00) $(0.00) $(0.00) $(0.00)                 Weighted average number of common shares outstanding - basic and diluted  654,797,086   449,266,866   599,035,774   422,070,403 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

 F-3Table of Contents

XERIANT, INC. 

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT 

FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2025 

UNAUDITED 

   Series A Preferred Stock    Series B Preferred Stock    Common Stock   stock  to be    Additional Paid in    Accumulated     Non-Controlling      Shares   Amount  Shares   Amount   Shares  Amount  issued   Capital   Deficit  Interest   Total  Balance June 30, 2024  705,895  $7   1,000,000  $10   524,853,304  $5,248  $51,950  $20,899,187  $(26,708,915 ) $(2,859,941 ) $(8,612,454 )                                             Stock issued for services  -   -   -   -   11,902,182   119   -   217,393   -   -   217,512                                              Conversion of Series A Preferred to Common Stock  (6,479 )  -   -   -   6,479,000   65   -   (65 )  -   -   -                                              Conversion of convertible notes payable and accrued interest into common stock  -   -   -   -   26,950,000   270   -   269,231   -   -   269,